Pharmacokinetic parameters of inhaled anaesthetics have previously been assessed experimentally in healthy volunteers. In contrast, we developed a method to estimate pharmacokinetic parameters under clinical conditions. We obtained data from the continuous routine monitoring of fractional concentration and ventilation during anaesthesia with desflurane, isoflurane and sevoflurane. By simulation studies, we assessed the effects of several sources of variation, including the noise of measurement, the second gas effect and rounding errors or a limited number of displayed digits. Stable fits to a two-compartment model were obtained for both real and simulated data sets in all cases. The most stable parameter was the intercompartmental clearance, and the most sensitive parameter was the volume of distribution. The bias in pharmacokinetic parameters caused by adding errors to measured concentrations was similar for the different compounds. We conclude that the model allows the estimation of an alternative set of pharmacokinetic parameters that can reliably describe the behaviour of volatile anaesthetics under clinical conditions, and allow comparison between agents.
The pharmacokinetics of inhaled anaesthetics has been kinetic variables difficult to assess. As pharmacokinetic parameters vary between subjects, an adequate number of assessed in experimental settings in healthy volunteers. subjects must be investigated in order to obtain reliable Previous studies obtained classical wash-in and wash-out mean values. For the comparison of different compounds, curves from step changes of the inspired partial pressure of intraindividual variation must also be considered. One the anaesthetic. 1-3 These curves are easily analysed, even of the merits of a purely experimental approach, with with graphical methods, to give different time constants simultaneous administration of several anaesthetics, is that representing different virtual volumes of distribution. Blood intraindividual variability is minimized. However, for ethical or expired vapour partial pressures in these studies were and cost reasons, only a few subjects were tested in such determined by gas chromatography. Samples from the blood studies. 2 3 or the expired gas were taken first at frequent intervals
In the present investigation, we examined an alternative (1-3 min), and subsequently less frequently. During washapproach. In current anaesthetic workstations, ventilatory out, samples were drawn for up to several days after drug variables as well as the inspired and end-tidal anaesthetic administration, allowing the construction of pharmacoconcentrations are measured continuously and recorded kinetic models with up to four or five compartments. [1] [2] [3] frequently. Therefore, from a formal point of view, the These experimental conditions are not easily transferred input function (x i (t)) and the system response (output to clinical anaesthesia, when volatile anaesthetic partial function, x o (t)) of the pharmacokinetic system under investipressure is increased or decreased in relation to the surgical stimulus. The variable inspired and end-tidal partial pressure †This article is accompanied by Editorial I. derived from the inspired and end-expired vapour concentration vs time and alveolar ventilation using a two-compartment model. The central compartment includes the lung and very rapidly equilibrating tissues (not anatomically by the time course of F I and the uptake, the system response x o (t) by the The data were also assessed using a corresponding threetime course of F E . The transfer function G(t) can be determined when the time course of the input and the output function are known. compartment model, but this gave stable results in only 50% of data sets and is therefore not described further. gation is recorded almost continuously, so that we can
The following pharmacokinetic parameters were derived determine the characteristics of the transfer system. Figure 1 from inspired and end-expired concentration values and illustrates the formal description of the transfer system. As alveolar ventilation: volume of distribution in the central a function vs time it is described by pharmacokinetic compartment, V 1 ; intercompartmental clearance, CL 12 , parameters. Pharmacokinetic methods can be used to measuring transport into the periphery; and microconstant, describe the transfer function and to determine the implicit k 21 , for transit from the periphery. To this end, a twodifferential equations.
compartment model was applied to describe changes of We set out to develop and describe a method that can expired concentrations (equation 1) and concentration in the derive pharmacokinetic parameters for inhaled anaesthetics peripheral compartment (equation 2) for inhaled anaesthetics from routine data in patients, and to assess the stability of with time: the parameter estimates obtained. We used clinical data for d the entire period of anaesthesia from intubation to extubation
(1) to establish a two-compartment model and to estimate dt pharmacokinetic parameters. We found distinct differences d between desflurane, isoflurane and sevoflurane other than
(2) differences that could be attributed to their physicochemical dt properties. [4] [5] [6] [7] V 1 and V 2 denote the central and peripheral volume of distribution respectively, k 12 and k 21 the microconstants, F 1
Methods
and F 2 the fraction of anaesthetic vapour in the central and
Acquisition of experimental data
peripheral compartments respectively, and V alv the alveolar Data from low-flow anaesthesia in 48 patients receiving ventilation. Because the system assumes that the central desflurane, isoflurane or sevoflurane (16 patients for each volume of distribution is well stirred, F 1 is assumed to anaesthetic) were used. Mean duration of anaesthesia was equal the fraction of anaesthetic in the end-expired gas, 111 (SD 44) min for desflurane, 148 (41) min for isoflurane F E Ј. Thus, F E Ј is used subsequently in place of F 1 . In and 115 (57) min for sevoflurane. Details of anaesthesia are addition, the uptake of volatile anaesthetic U(t) can be described in the accompanying paper. 4 The concentrations of expressed as these compounds and the ventilation data provided by the
monitoring system of the Ohmeda Modulus CD/CV were recorded at 20-s intervals using the integrated floppy disk
The following equation was used for the calculation of drive. Alveolar ventilation (V alv ) was estimated from the intercompartmental or transport clearance CL 12 : expiratorily measured tidal volume (V T ) less a dead space CL 12 ϭ k 12 V 1 ϭ k 21 V 2 (4) of 2.0 ml per kg body weight, corresponding to 25% of the set tidal volume. 8 Based upon this definition, equations (1) and (2) become After calibration, the accuracy of the internal gas analyser d of the Ohmeda Modulus CD/CV was assessed using mix-
tures of calibration vapour and ambient air. In the range dt from 0 to 1.1 vol% isoflurane the variation was less than d Ϯ0.5 of the least significant digit. The accuracy was the V 2 F 2 ϭ -CL 12 F E Ј -CL 12 F 2 (6) same after 6 h of continuous working and after 1 week. dt A modified Ohmeda Miniabsorber System circle system Solving for F E Ј and F 2 yields was used which did not influence the measured inspiratory concentration. 9 The accuracy of the turbine volumeter was d CL 12 CL 12 U(t) measured by ventilating an adiabatic test lung. Variation
V 1 was less than Ϯ5% throughout the operating range.
Estimation of parameters
Based on the direct relationship between the volume of a dt V 2 V 2 gas and its molar mass, pharmacokinetic parameters were The microconstant k 21 can be interpreted as the inverse of Study D: random error of the output signal the transit time in the periphery. Subsequently, we used V 1 , The sampled expiratory concentrations were distorted by CL 12 and k 21 to characterize the two-compartment model. log-normally distributed random noise (σϭ0.1). The solution of the differential equation can be obtained In all cases, simulation was based on the 16 measured by solving the two-compartment model with zero order time courses of desflurane, isoflurane and sevoflurane anaesabsorption for each sampling interval after algebraic manip-thesia. 4 When random errors were applied (in studies A, B ulation of the uptake term. The differential equations were and D), 20 data sets were generated based on each of the solved explicitly for each sampling interval to obtain the measured time courses. From these simulated data sets, calculated expired fractional concentration, F E Ј ,calc . F E Ј ,calc pharmacokinetic parameters were estimated as described was then fitted to the observed values by the least squares above. The mean difference between the model parameters method based on the simplex algorithm. 10 An additive error determined from the measured time courses and those model was assumed because the rounding errors of the determined from the perturbed time courses was defined as recorded concentrations are absolute errors.
bias. The mean coefficient of variation of the parameters estimated from artificially perturbed time courses was
Simulation studies defined as scatter. We assessed the robustness of the parameter estimates. These estimates may be influenced by factors such as Results measurement noise, changes in carbon dioxide, oxygen and water concentrations in the measured volumes, the second Goodness of fit gas effect, 11-14 rounding errors of the measurement device, Stable fits were achieved with the two-compartment model and a limited number of displayed digits. In the pharmacodescribed for both real and simulated data sets in all cases. kinetic system, measurement noise is present in the input
The average (SD) of the root mean square errors for F E Ј ,calc and output variables. Because of subsequent calculation of were 0.16 (0.04) (max. 0.21) vol% for desflurane, 0.05 end-expired concentrations, the second gas effect, mimick-(0.01) (max. 0.07) vol% for isoflurane and 0.05 (0.01) ing an increase in ventilation, may be important at the start (max. 0.08) vol% for sevoflurane in real data sets, while of anaesthesia. It can be simulated by an artificial increase measured expiratory concentrations reached 9.5 vol% for in uptake. The loss of precision as a result of rounding desflurane, 1.5 vol% for isoflurane and 3.4 vol% for errors by the measurement device may be assessed by sevoflurane. normally distributed random replications.
In no case did the individual plots of residuals vs time Thus, the effect of the presumed confounding factors can and estimated vs measured concentration show that the be assessed from the dependence of the curve fit on random model was incorrect. To illustrate the goodness of fit for and/or systematic error of the input signal, on the sampling each of the volatile anaesthetics, the residuals of the data rate and on random error of the output signal.
sets with the highest mean square errors are shown in In the following simulation studies using published rou- Figure 2 . tines, 10 we made worst-case assumptions about the magni-
The results from the original data sets are reported in the tude of the error that could confound the estimation of the accompanying paper. 4 pharmacokinetic parameters.
Study A: random error of the input signal

Robustness of parameter estimates
To consider this uncertainty in the uptake U(t), the input The bias and scatter for the parameters V c , CL 12 and k 21 variables F I and V alv were disturbed simultaneously by are shown in Tables 1, 2 and 3 respectively. The scatter independent log-normally distributed random noise. A reflects the introduced error in all cases. The most stable standard deviation of σϭ0.1 was used to simulate arbitrary parameter was the intercompartmental clearance. The volnon-specific noise causing 10% variation in both input ume of distribution was more dependent on the magnitude variables, and σϭ0.025 was applied to assess the 2.5% of error than the remaining parameters. The data with 20% increase in variation expected by the round-off error at a initial systematic error, simulating a second gas effect, gave concentration of 1-10 vol% when two digits were available. the largest bias; visual examination of the residual plots Study B: systematic bias combined with round-off error of shows a slightly impaired fit for the first 10 min. The effect the input signal of variation in the input value was considerably more For the initial 10 min the uptake was increased by a factor pronounced than that of the output value. A reduction of of 1.2 to simulate an initial second gas effect. For the the sampling rate to 1/4 changed the estimated volume of round-off error of the uptake, σϭ0.025 was assumed, as in distribution by up to 43% (mean), whereas the other study A.
parameters were not changed by more than 15% (mean). The impact of the error introduced in the parameter estimates Study C: decreased sampling rate was similar for the different inhaled anaesthetics, although The sampling rate was diminished by factors of 2, 3 and 4 to determine its influence.
isoflurane, the compound with the largest time constants, otherwise parameter estimation might become unstable; d The model should incorporate transport to a peripheral compartment; d The method should not be affected by systematic and random errors. In this study, we applied the least squares method using anaesthesia for the data sets with the poorest fits. Mean F E for the whole the end-expired fractional concentration as the dependent course of anaesthesia in these cases was 5.1, 0.9 and 1.5 vol% for variable. This is because standard maximum likelihood desflurane, isoflurane and sevoflurane respectively. The deviation 'spikes' methods comprising the statistical error of the dose adminisin the isoflurane course were caused by invalid data from the gas analyser tered would yield a large covariance matrix, which cannot be during calibration not eliminated in the referenced raw data set.
inverted by standard methods within a reasonable computing time. The maximum likelihood procedure is based on the parameterised distribution of the observed values and selects was somewhat less affected than the other compounds. An those parameters with the largest likelihood for the observed individual time profile with a steep concentration change values. If these are uncorrelated and normally distributed, for sevoflurane, including the fitted curve obtained with the maximum likelihood approach coincides with the least perturbation, is shown in Figure 3 . squares method. 15 Quality of fit can be quantified using the root mean Discussion square error. As its values were small compared with the measured concentrations, estimated values for F E Ј in general This method for the determination of the pharmacokinetics of volatile anaesthetics using routine clinical data should described the measured data very precisely. In addition, the root mean square errors of the data sets with the poorest have advantages compared with experimental measurements. 1-3 These include the number of patients that may be fit exceeded the mean values by not more than 1.6-fold, showing that the model used was satisfactory in all cases. investigated, the frequency of sampling, the fact that it is non-invasive and that it takes into account possible feedback Even for these data sets, the residuals vs time plots do not suggest misspecification of the model (Fig. 2) . The of physiological effects of the individual agent on its own pharmacokinetic properties, and the lower cost of observation that the root mean square errors were within the magnitude of rounding errors suggests that improving measurement. However, these advantages may be unimportant if the estimation of parameters by this method is subject the fit by the use of more complex models is not generally feasible. This is supported by the finding that stable estimates to important bias. Therefore, we required a model with the following properties:
of pharmacokinetic parameters for a three-compartment model could not be obtained in 50% of the data sets, d The model should be as simple as possible since 
and that multicompartment models such as those derived are not relevant to the concentration in the central compartment. experimentally 1-3 were not appropriate. It therefore appears that during clinical anaesthesia under the conditions exam-
The random error used in the simulation studies to disturb input and output variables represents the round-off error ined here, slow transport processes to a third compartment are of minor importance, and to a fourth or fifth compartment and the uncertainty of the measurement. The round-off error accounts for not more than 2.5% when two digits are method described are valid even if the true errors are at the upper limit of those described above. available and the fractional concentration is in the range of Our procedure provides an alternative set of pharmaco-1-10 vol% (for 1.0 vol%, maximal round-off error is 0.05ϭ kinetic parameters that can describe the behaviour of volatile 5%, and minimal round-off error is zero, giving a mean anaesthetics under clinical conditions. Because of the simplierror of 2.5%). Since the accuracy of the measurement was city of the methods used, it appears possible to conduct onbetter than the round-off error, it is supposed that the overall line estimations of individual pharmacokinetic parameters random error is closer to 2.5 than to 10%. Other sources during anaesthesia. These estimates may serve to predict of error include the effects on inspired and expired measurethe individual behaviour of patients, such as forecasting the ments of volumes and concentrations of inhaled agents duration of coasting to a given end-tidal concentration, and caused by changes in carbon dioxide, oxygen and water thus to improve patient control. concentrations. No corrections were made for water vapour and respiratory quotient; however, they are included, at
